$8.880
-0.069 (-0.78%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
XLO 相似圖表分析預測
Alphio's XLO stock price prediction model matches the current Xilio Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.89 (+0.59%). The 1-week path is $8.85 (+0.10%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Xilio Therapeutics Inc 股票嗎?
Xilio Therapeutics Inc is currently not a strong buy due to its recent performance and financial instability. The stock closed at $9.00, with a 5-day change of -2.49% and a year-to-date change of -4.29%. While there is potential for future growth, as indicated by a projected trajectory of +931.59%, the current RSI of 30.047 suggests the stock is oversold, which could indicate a potential rebound. However, the main risk is the negative net income reported for Q1 2026 at -$9.5 million, which reflects ongoing financial challenges.
XLO 股價於 Tuesday 收在 $8.88,此前下跌 -0.78%
Xilio Therapeutics Inc (XLO) last closed at $8.84, losing -0.45%. These facts feed the 1-day and 1-week XLO price prediction above.
預測驅動因素
Xilio Therapeutics Inc(XLO)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
相似圖表形態
近期走勢與 XLO 最接近的股票,依相似度排序。
XLO 季節性分析
Historically the probability of a positive September return for XLO is 46.51%. January offers the highest probability of a positive month at 55.74%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。